Wearable device for detecting seizures

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the accuracy of a wearable seizure detection device called EarSD in patients with epilepsy. Participants will wear the device while undergoing long-term video-EEG monitoring in the Epilepsy Monitoring Unit. The study aims to determine if the EarSD device can provide comfort, be unobtrusive during daily activities, and offer additional insights into seizure control. The results will be compared with conventional EEG recordings to assess the device's effectiveness.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age ≥ 18 years.
2. Patients admitted to UMass Memorial Epilepsy Monitoring Unit (EMU) for long term video-EEG monitoring as part of standard care of both focal and generalized epilepsy.
3. Willing to wear the wearable device.
4. Ability to provide informed consent

Exclusion Criteria:

1. Subjects wearing other ear devices such as hearing aids.
2. Inability or unwillingness to provide informed consent.
3. Irritation of the skin where the device is to be placed.
4. Patients with intracranial electrodes placement.
5. Prisoners
6. Cognitive impaired individuals
7. Pregnant Women
8. Children (Age 0-17)

Where it's running

• Ummmc-Memorial Campus
  Worcester, Massachusetts, United States Recruiting
• Ummmc-University Campus
  Worcester, Massachusetts, United States Recruiting

Study contacts

• Principal investigator: Felicia Chu, MD — UMass Neurology Department
• Study coordinator: Stephanie Stephens
• Email: Stephanie.Stephens1@umassmed.edu
• Phone: 508-856-3939

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Levetiracetam to prevent seizures in adults with Down syndrome and Alzheimer's disease

  This trial will test whether the anti-seizure medicine levetiracetam can prevent tonic-clonic seizures and slow cognitive decline in adults over 40 who have Down syndrome and symptomatic Alzheimer's disease.

  Recruiting Phase 3 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Granada, Andalusia and 4 other locations · NCT07234695

• Investigating factors that lead to epilepsy after a stroke

  This study is trying to find out what factors might cause epilepsy in people who have had a stroke by comparing them to healthy individuals.

  Recruiting Norwegian University of Science and Technology · Trondheim · NCT05864547

• Effects of scopolamine on brain activity related to memory in epilepsy patients

  This study is testing if the drug scopolamine can change how well people with epilepsy remember things by looking at their brain activity while they do memory tasks.

  Recruiting Early Phase 1 University of Texas Southwestern Medical Center · Dallas, Texas · NCT05594017

• Creation of a database linking EEG recordings with clinical information for epilepsy patients

  This study is creating a database that links brain wave recordings and medical information from epilepsy patients to see if it can help improve treatment and predict seizures better.

  Recruiting University of New Mexico · Albuquerque, New Mexico · NCT05140265

• Analyzing brain imaging biomarkers in patients with cerebral cavernous malformation-related epilepsy

  This study is trying to see if brain scans can help find signs of iron buildup in people with cerebral cavernous malformation and epilepsy, which could improve how we manage their condition.

  Recruiting at 2 sites Beijing Tiantan Hospital · Beijing, Beijing Municipality and 1 other locations · NCT04076449

• Investigating epilepsy and its treatment options

  This study is looking to better understand epilepsy and improve treatments for people aged 8 and older who have drug-resistant epilepsy by examining their medical history and conducting tests.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT03478852

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.